Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · December 17, 2024

Peri-Levator Betamethasone vs Triamcinolone Injection in the Management of Thyroid Eye Disease–Related Upper Eyelid Retraction Without Proptosis

Ophthalmic Plastic and Reconstructive Surgery

 

Additional Info

Ophthalmic Plastic and Reconstructive Surgery
Peri-levator Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease-related Upper Eyelid Retraction Without Proptosis
Ophthalmic Plast Reconstr Surg 2024 Nov 01;40(6)610-616, RA Awad, AA Abo-Ghadir, MS Hussien, AA Awad, SM Kedwany, AEA Mohammad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading